# Pharmacokinetic Study of Diazoxide Choline in Hypertriglyeridemic Subjects

> **NCT01211860** · PHASE1 · COMPLETED · sponsor: **Essentialis, Inc.** · enrollment: 9 (actual)

## Conditions studied

- Hypertriglyceridmia

## Interventions

- **DRUG:** Diazoxide Choline Controlled-Release Tablet

## Key facts

- **NCT ID:** NCT01211860
- **Lead sponsor:** Essentialis, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2014-01-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01211860

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01211860, "Pharmacokinetic Study of Diazoxide Choline in Hypertriglyeridemic Subjects". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01211860. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*